Adaptimmune Therapeutics PLC Contracts & Agreements

78 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Employment Agreement dated as of December 16, 2020 by and between Adaptimmune, LLC and Elliot Norry
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
PA
2020
Mutual Release and Resolution Agreement dated September 23, 2024 by and among Adaptimmune Limited, Genentech, Inc., and F. Hoffman La-Roche Ltd
Release Agreements
Adaptimmune Therapeutics PLC
2024
Executive Severance Policy of Adaptimmune Therapeutics plc dated March 10, 2017 and amended and restated effective as of June 11, 2024 and on July 16, 2024
Severance Agreements
Adaptimmune Therapeutics PLC
2024
Executive Severance Policy of Adaptimmune Therapeutics plc dated March 10, 2017 and amended and restated effective as of June 11, 2024
Severance Agreements
Adaptimmune Therapeutics PLC
2024
Description of the Registrants Securities
Adaptimmune Therapeutics PLC
2024
Employment Agreement dated February 26, 2024 by and between Adaptimmune, LLC and Cintia Piccina
Employment Agreements
Adaptimmune Therapeutics PLC
2024
Adaptimmune Therapeutics plc 2015 Share Option Scheme
Share Agreements
Adaptimmune Therapeutics PLC
2023
Adaptimmune Therapeutics plc 2016 Employee Share Option Scheme
Share Agreements
Adaptimmune Therapeutics PLC
2023
AdaptimmuneTherapeutics plc, 60 Jubilee Avenue, Milton Park, Abingdon, Oxfordshire OX14 4RX, United Kingdom T: +44 (0)1235 430000 www.adaptimmune.com Registeredin England no:...
Adaptimmune Therapeutics PLC
2023
AdaptimmuneTherapeutics plc, 60 Jubilee Avenue, Milton Park, Abingdon, Oxfordshire OX14 4RX, United Kingdom T:+44 (0)1235 430000 www.adaptimmune.com Registered in England no:...
Adaptimmune Therapeutics PLC
2023
AdaptimmuneTherapeutics plc, 60 Jubilee Avenue, Milton Park, Abingdon, Oxfordshire OX14 4RX, United Kingdom T: +44 (0)1235 430000 www.adaptimmune.comRegistered in England no:...
Adaptimmune Therapeutics PLC
2023
Termination and Transfer Agreement made and effective as of April 6, 2023 by and between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd
Termination Agreements
Adaptimmune Therapeutics PLC
Biotechnology
CA
2023
Amendment No. 1 to the Agreement and Plan of Merger, dated as of April 5, 2023, by and among Adaptimmune Therapeutics plc, CM Merger Sub, Inc. and TCR
Merger Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2023
Form of Voting and Support Agreement, dated as of March 5, 2023, by and among Adaptimmune, TCR2 and certain stockholders of TCR2
Voting Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2023
Separation and Consulting Agreement dated as of March 3, 2023 by and between Adaptimmune, LLC and Cintia Piccina and effective as of March 5, 2023
Consulting Agreements
Adaptimmune Therapeutics PLC
2023
Form of Voting and Support Agreement, dated as of March 5, 2023, by and among Adaptimmune, TCR2 and certain shareholders of Adaptimmune
Voting Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2023
Agreement and Plan of Merger, dated as of March 5, 2023, by and among Adaptimmune, CM Merger Sub, Inc. and TCR2
Merger Agreements
Adaptimmune Therapeutics PLC
2023
Description of the Registrants Securities
Adaptimmune Therapeutics PLC
Biotechnology
NY
2023
Letter of Appointment dated February 15, 2023 between Adaptimmune Therapeutics plc and Kristen Hege and effective from November 1, 2023
Adaptimmune Therapeutics PLC
Biotechnology
2023
Amendment Agreement No. 8 made and effective as of December 19, 2022 by and between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd
Development Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2022
Deed of Variation dated June 15, 2022, between MEPC Milton Park No 1 Limited and MEPC Milton Park No. 2 Limited and Adaptimmune Limited relating to a lease of 39 Innovation Drive,...
Lease Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2022
Deed of Surrender of Part dated June 15, 2022, between MEPC Milton Park No 1 Limited and MEPC Milton Park No. 2 Limited and Adaptimmune Limited relating to a lease of 39...
Lease Agreements
Adaptimmune Therapeutics PLC
2022
Employment Agreement dated as of May 4, 2022 by and between Adaptimmune Limited and Joanna Brewer
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2022
Description of the Registrants Securities
Adaptimmune Therapeutics PLC
2022
Employment Agreement dated as of January 26, 2022 by and between Adaptimmune, LLC and Cintia Piccina
Employment Agreements
Adaptimmune Therapeutics PLC
2022
Rent Security Deposit Deed dated August 20, 2021, between MEPC Milton Park No 1 Limited and MEPC Milton Park No. 2 Limited, Adaptimmune Limited and Adaptimmune Therapeutics plc...
Security Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2021
Deed of Variation dated August 20, 2021, between MEPC Milton Park No 1 Limited and MEPC Milton Park No. 2 Limited and Adaptimmune Limited relating to a lease of 39 Innovation...
Lease Agreements
Adaptimmune Therapeutics PLC
2021
Deed of Variation dated August 13, 2021, between MEPC Milton Park No 1 Limited and MEPC Milton Park No. 2 Limited, Adaptimmune Limited and Adaptimmune Therapeutics plc relating to...
Lease Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2021
Agreement dated August 13, 2021, between MEPC Milton Park No 1 Limited and MEPC Milton Park No. 2 Limited, Adaptimmune Limited and Adaptimmune Therapeutics plc relating to 39...
Adaptimmune Therapeutics PLC
Biotechnology
2021
Description of the Registrants Securities
Adaptimmune Therapeutics PLC
2021
Underwriting Agreement, dated June 1, 2020, by and among Adaptimmune Therapeutics plc, Cowen and Company, LLC and SVB Leerink LLC, as representative of the several Underwriters...
Underwriting Agreements
Adaptimmune Therapeutics PLC
2020
Collaboration and License Agreement, dated January 13, 2020, by and between Universal Cells, Inc. and Adaptimmune Limited
Collaboration Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2020
Description of the Registrants Securities
Adaptimmune Therapeutics PLC
Biotechnology
NY
2020
Variation Agreement dated as of February 17, 2020 by and between Adaptimmune, LLC and La Fosse Associates Limited
Adaptimmune Therapeutics PLC
2020
Variation Agreement dated as of February 17, 2020 by and between La Fosse Associates Limited, GAR-1 Business Advisory Services and Adaptimmune, LLC
Services Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2020
Service Agreement dated as of February 17, 2020 by and between Adaptimmune Limited and Gavin Wood
Services Agreements
Adaptimmune Therapeutics PLC
2020
Underwriting Agreement, dated January 22, 2020, by and between Adaptimmune Therapeutics plc and Cowen and Company, LLC, as representative of the several Underwriters named therein
Underwriting Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2020
Senior Vice President Severance Policy dated December 4, 2019
Severance Agreements
Adaptimmune Therapeutics PLC
2020
Employment Agreement dated as of January 13, 2020 by and between Adaptimmune, LLC and Elliot Norry
Employment Agreements
Adaptimmune Therapeutics PLC
2020
Agreement dated as of September 30, 2019 by and between La Fosse Associates Limited, GAR-1 Business Advisory Services and Adaptimmune, LLC
Services Agreements
Adaptimmune Therapeutics PLC
2019
Agreement dated as of September 30, 2019 by and between La Fosse Associates Limited and Adaptimmune, LLC
Adaptimmune Therapeutics PLC
Biotechnology
2019
Collaboration Agreement dated as of August 26, 2019 by and among Adaptimmune Limited and Noile-Immune Biotech, Inc
Collaboration Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2019
Collaboration Agreement dated May 14, 2019 between Adaptimmune Limited and AIS Operating Co., Inc., f/k/a Alpine Immune Sciences, Inc
Collaboration Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2019
Employment Agreement dated as of August 1, 2019 by and between Adaptimmune, LLC and John Lunger
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
PA
2019
James Noble Letter Agreement dated June 26, 2019
Adaptimmune Therapeutics PLC
2019
Employment Agreement dated as of June 26, 2019 by and between Adaptimmune, LLC and Adrian Rawcliffe
Employment Agreements
Adaptimmune Therapeutics PLC
2019
James Noble Variation Agreement dated June 26, 2019
Adaptimmune Therapeutics PLC
2019
James Noble Letter of Appointment dated June 26, 2019
Adaptimmune Therapeutics PLC
Biotechnology
2019
Purchase Agreement, dated September 5, 2018, between Adaptimmune Therapeutics plc and Matrix Capital Management Master Fund, LP, New Enterprise Associates 16, L.P, New Enterprise...
Purchase Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2018
Amendment Agreement No. 6, dated July 20, 2018 between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd
Development Agreements
Adaptimmune Therapeutics PLC
2018
Collaboration Agreement, dated January 5, 2018, between Adaptimmune Limited and Cell Therapy Catapult Limited
Collaboration Agreements
Adaptimmune Therapeutics PLC
2018
First Amendment to Employment Agreement, dated January 12, 2018 and effective October 30, 2017, between Adaptimmune LLC and Gwendolyn Binder-Scholl
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2018
Lease, dated February 28, 2018, between MEPC Milton Park No. 1 Limited, MEPC Milton Park No. 2 Limited and Adaptimmune Limited relating to 39 Innovation Drive, Milton Park
Lease Agreements
Adaptimmune Therapeutics PLC
2018
Rent Security Deposit Deed, dated February 28, 2018, between MEPC Milton Park No. 1 Limited, MEPC Milton Park No. 2 Limited and Adaptimmune Limited relating to 39 Innovation...
Security Agreements
Adaptimmune Therapeutics PLC
2018
Rules of the Adaptimmune Therapeutics plc 2015 Share Option Scheme, dated March 16, 2015, as amended April 15, 2015, January 13, 2016 and December 18, 2017
Share Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2018
Rules of the Adaptimmune Therapeutics plc 2016 Employee Share Option Scheme, dated January 14, 2016, as amended December 18, 2017
Share Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2018
Amendment Agreement No. 5, dated September 7, 2017 between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd
Development Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2017
ADAPTIMMUNE THERAPEUTICS PLC (a public limited company organized under the laws of England and Wales) 7,000,000 American Depositary Shares Representing an Aggregate of 42,000,000...
Purchase Agreements
Adaptimmune Therapeutics PLC
2017
ADAPTIMMUNE THERAPEUTICS PLC (a public limited company organized under the laws of England and Wales) 14,300,000 American Depositary Shares Representing an Aggregate of 85,800,000...
Underwriting Agreements
Adaptimmune Therapeutics PLC
2017
EMPLOYMENT AGREEMENT
Employment Agreements
Adaptimmune Therapeutics PLC
2017
CO-DEVELOPMENT AND CO-COMMERCIALISATION AGREEMENT BETWEEN ADAPTIMMUNE LIMITED AND BELLICUM PHARMACEUTICALS, INC.
Adaptimmune Therapeutics PLC
2017
DATED 10 March 2017 (1) ADAPTIMMUNE THERAPEUTICS PLC and (2) J.J. NOBLE SERVICE AGREEMENT
Services Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2017
EMPLOYMENT AGREEMENT
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
PA
2017
EMPLOYMENT AGREEMENT
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
PA
2017
EXECUTIVE SEVERANCE POLICY
Severance Agreements
Adaptimmune Therapeutics PLC
2017
STRATEGIC ALLIANCE AGREEMENT
Adaptimmune Therapeutics PLC
2016
Adaptimmune Therapeutics plc, 101 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom T: +44 (0)1235 430000 www.adaptimmune.com Registered in England no:...
Adaptimmune Therapeutics PLC
Biotechnology
2016
Adaptimmune Therapeutics plc, 101 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom T: +44 (0)1235 430000 www.adaptimmune.com Registered in England no:...
Adaptimmune Therapeutics PLC
Biotechnology
2016
FIRST AMENDMENT TO EMPLOYMENT AGREEMENT
Employment Agreements
Adaptimmune Therapeutics PLC
2016
SERVICES AGREEMENT
Services Agreements
Adaptimmune Therapeutics PLC
2016
PRESCRIBED CLAUSES
Adaptimmune Therapeutics PLC
Biotechnology
2016
CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT by and between Merck Sharp & Dohme B.V., and Adaptimmune Limited Dated: October 27th, 2016
Collaboration Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2016
Adaptimmune Therapeutics plc, 101 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom T: +44 (0)1235 430000 www.adaptimmune.com Registered in England no:...
Adaptimmune Therapeutics PLC
2016
Adaptimmune Therapeutics plc, 101 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom T: +44 (0)1235 430000 www.adaptimmune.com Registered in England no:...
Adaptimmune Therapeutics PLC
2016
Adaptimmune Therapeutics plc, 101 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom T: +44 (0)1235 430000 www.adaptimmune.com Registered in England no:...
Adaptimmune Therapeutics PLC
2016
Adaptimmune Therapeutics plc, 101 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom T: +44 (0)1235 430000 www.adaptimmune.com Registered in England no:...
Adaptimmune Therapeutics PLC
Biotechnology
WI
2016
Adaptimmune Therapeutics plc, 101 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom T: +44 (0)1235 430000 www.adaptimmune.com Registered in England no:...
Adaptimmune Therapeutics PLC
2016
Adaptimmune Therapeutics plc, 101 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom T: +44 (0)1235 430000 www.adaptimmune.com Registered in England no:...
Adaptimmune Therapeutics PLC
2016